These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7570678)

  • 1. Physiologically based pharmacokinetic models: mathematical fundamentals and simulation implementations.
    Hoang K
    Toxicol Lett; 1995 Sep; 79(1-3):99-106. PubMed ID: 7570678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug-Drug Interaction Prediction.
    Chen Y; Ma F; Lu T; Budha N; Jin JY; Kenny JR; Wong H; Hop CE; Mao J
    Clin Pharmacokinet; 2016 Jun; 55(6):735-49. PubMed ID: 26692192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
    Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N
    Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model.
    Kuepfer L; Niederalt C; Wendl T; Schlender JF; Willmann S; Lippert J; Block M; Eissing T; Teutonico D
    CPT Pharmacometrics Syst Pharmacol; 2016 Oct; 5(10):516-531. PubMed ID: 27653238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
    Frechen S; Rostami-Hodjegan A
    Pharm Res; 2022 Aug; 39(8):1733-1748. PubMed ID: 35445350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.
    Zhao P; Zhang L; Grillo JA; Liu Q; Bullock JM; Moon YJ; Song P; Brar SS; Madabushi R; Wu TC; Booth BP; Rahman NA; Reynolds KS; Gil Berglund E; Lesko LJ; Huang SM
    Clin Pharmacol Ther; 2011 Feb; 89(2):259-67. PubMed ID: 21191381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
    Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in methodology of establishing physiologically based pharmacokinetic models].
    Jin YW; Ma YM
    Yao Xue Xue Bao; 2014 Jan; 49(1):16-22. PubMed ID: 24783500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Windows based general PBPK/PD modeling software.
    Luecke RH; Pearce BA; Wosilait WD; Doerge DR; Slikker W; Young JF
    Comput Biol Med; 2008 Sep; 38(9):962-78. PubMed ID: 18657803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.
    Li M; Zou P; Tyner K; Lee S
    AAPS J; 2017 Jan; 19(1):26-42. PubMed ID: 27834047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a hybrid physiologically based pharmacokinetic model with drug-specific scaling factors in rat to improve prediction of human pharmacokinetics.
    Sayama H; Komura H; Kogayu M; Iwaki M
    J Pharm Sci; 2013 Nov; 102(11):4193-204. PubMed ID: 24018828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares.
    Haddad S; Pelekis M; Krishnan K
    Toxicol Lett; 1996 May; 85(2):113-26. PubMed ID: 8650694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
    Peters SA; Ungell AL; Dolgos H
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?
    Bouzom F; Ball K; Perdaems N; Walther B
    Biopharm Drug Dispos; 2012 Mar; 33(2):55-71. PubMed ID: 22228149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations.
    Rhee SJ; Chung H; Yi S; Yu KS; Chung JY
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):973-980. PubMed ID: 28536774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: A bottom up modeling approach.
    Sharma RP; Schuhmacher M; Kumar V
    Toxicol Lett; 2018 Oct; 296():152-162. PubMed ID: 29958929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMATRIX: software for physiologically based pharmacokinetic modeling using a symbolic matrix representation system.
    Ball R; Schwartz SL
    Comput Biol Med; 1994 Jul; 24(4):269-76. PubMed ID: 7842649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
    Poulin P; Theil FP
    J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.